Literature DB >> 32011369

Reply to the Letter to the Editor: Combined Intravenous and Intraarticular Tranexamic Acid Does Not Offer Additional Benefit Compared with Intraarticular Use Alone in Bilateral TKA: A Randomized Controlled Trial.

Prashant Meshram1, Jeya Venkatesh Palanisamy1, Jong Yeon Seo1, Jong Geun Lee1, Tae Kyun Kim2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32011369      PMCID： PMC7282604          DOI： 10.1097/CORR.0000000000001159

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.755


× No keyword cloud information.
  26 in total

1.  Editorial: The Minimum Clinically Important Difference-The Least We Can Do.

Authors:  Seth S Leopold; Raphaël Porcher
Journal:  Clin Orthop Relat Res       Date:  2017-01-25       Impact factor: 4.176

2.  Tranexamic Acid Use in Total Joint Arthroplasty: The Clinical Practice Guidelines Endorsed by the American Association of Hip and Knee Surgeons, American Society of Regional Anesthesia and Pain Medicine, American Academy of Orthopaedic Surgeons, Hip Society, and Knee Society.

Authors:  Yale A Fillingham; Dipak B Ramkumar; David S Jevsevar; Adolph J Yates; Stefano A Bini; Henry D Clarke; Emil Schemitsch; Rebecca L Johnson; Stavros G Memtsoudis; Siraj A Sayeed; Alexander P Sah; Craig J Della Valle
Journal:  J Arthroplasty       Date:  2018-08-07       Impact factor: 4.757

3.  Tranexamic acid administration is associated with an increased risk of posttraumatic venous thromboembolism.

Authors:  Sara P Myers; Matthew E Kutcher; Matthew R Rosengart; Jason L Sperry; Andrew B Peitzman; Joshua B Brown; Matthew D Neal
Journal:  J Trauma Acute Care Surg       Date:  2019-01       Impact factor: 3.313

4.  What is the Ideal Route of Administration of Tranexamic Acid in TKA? A Randomized Controlled Trial.

Authors:  Sung Yup Lee; Suri Chong; Dhanasekaraprabu Balasubramanian; Young Gon Na; Tae Kyun Kim
Journal:  Clin Orthop Relat Res       Date:  2017-03-10       Impact factor: 4.176

5.  Intra-articular injection of tranexamic acid reduces not only blood loss but also knee joint swelling after total knee arthroplasty.

Authors:  Kazunari Ishida; Nobuhiro Tsumura; Atsushi Kitagawa; Sayaka Hamamura; Koji Fukuda; Yoshihiro Dogaki; Seiji Kubo; Tomoyuki Matsumoto; Takehiko Matsushita; Takaaki Chin; Tetsuhiro Iguchi; Masahiro Kurosaka; Ryosuke Kuroda
Journal:  Int Orthop       Date:  2011-01-21       Impact factor: 3.075

6.  Evaluation of Military Use of Tranexamic Acid and Associated Thromboembolic Events.

Authors:  Luke R Johnston; Carlos J Rodriguez; Eric A Elster; Matthew J Bradley
Journal:  JAMA Surg       Date:  2018-02-01       Impact factor: 14.766

Review 7.  Is combined topical with intravenous tranexamic acid superior than topical, intravenous tranexamic acid alone and control groups for blood loss controlling after total knee arthroplasty: A meta-analysis.

Authors:  Chunmei Lin; Yingmei Qi; Li Jie; Hong-Biao Li; Xi-Cheng Zhao; Lei Qin; Xin-Qiang Jiang; Zhen-Hua Zhang; Liping Ma
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.889

8.  Comparison of the effectiveness and safety of topical versus intravenous tranexamic acid in primary total knee arthroplasty: a meta-analysis of randomized controlled trials.

Authors:  Tao-Ping Chen; Yu-Min Chen; Jian-Bao Jiao; Yun-Fei Wang; Li-Gang Qian; Zhao Guo; Zheng Ma; Cui-Yu Han; Tong-Huan Shi
Journal:  J Orthop Surg Res       Date:  2017-01-19       Impact factor: 2.359

9.  Combined Intravenous and Intraarticular Tranexamic Acid Does Not Offer Additional Benefit Compared with Intraarticular Use Alone in Bilateral TKA: A Randomized Controlled Trial.

Authors:  Prashant Meshram; Jeya Venkatesh Palanisamy; Jong Yeon Seo; Jong Geun Lee; Tae Kyun Kim
Journal:  Clin Orthop Relat Res       Date:  2020-01       Impact factor: 4.755

10.  The effectiveness and safety of tranexamic acid in bilateral total knee arthroplasty: A meta-analysis.

Authors:  Kedi Weng; Xingen Zhang; Qing Bi; Chen Zhao
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.